Saudi Arabia's Lifera advances national biotech strategy with investments in insulin manufacturing, genomics, and a new CDMO facility in Jeddah.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.